Utrecht, Netherlands

Roelof Peter Pickkers

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Am-Pharma B.v.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roelof Peter Pickkers. Retrieved from https://idiyas.com/inventor/roelof-peter-pickkers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Roelof P Pickkers - Innovative Inventor from Nijmegen

Introduction: Roelof P Pickkers is a renowned inventor hailing from Nijmegen, Netherlands, known for his groundbreaking contributions to the field of medical innovations.

Latest Patents: Roelof P Pickkers holds several patents in the medical industry, focusing on novel treatments for critical conditions such as sepsis and inflammatory diseases.

Career Highlights: With a career spanning over two decades, Roelof P Pickkers has worked tirelessly to bridge the gap between medical research and practical applications, leading to life-saving advancements in healthcare.

Collaborations: Throughout his career, Roelof P Pickkers has collaborated with leading pharmaceutical companies, research institutions, and medical professionals to bring his innovative ideas to fruition and positively impact patient outcomes.

Conclusion: Roelof P Pickkers' dedication to innovation and his relentless pursuit of improving medical treatments have solidified his position as a pioneering inventor in the field of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…